Dysplasia in ulcerative colitis?clinical consequences?
- 13 March 2004
- journal article
- review article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 389 (5) , 354-360
Abstract
The overall absolute risk of colorectal cancer (CRC) in longstanding extensive or total ulcerative colitis (UC) is estimated to be 10%–15%. The size of this risk is 6- to 10-times that expected in the background population. By performing complete colonoscopies with multiple biopsies from the entire colon and rectum at regular intervals, surveillance programmes for high-risk UC patients aim at detecting mucosal dysplasia in order to select CRC-prone individuals for prophylactic colectomy.Keywords
This publication has 56 references indexed in Scilit:
- Low-Grade Dysplasia in Extensive, Long-Standing Inflammatory Bowel DiseaseDiseases of the Colon & Rectum, 2002
- Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potentialHepatology, 1995
- Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitisDiseases of the Colon & Rectum, 1995
- Failure of colonoscopic surveillance in ulcerative colitis.Gut, 1993
- Surveillance in ulcerative colitis: burdens and benefit.Gut, 1988
- Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.Gut, 1988
- Colon Cancer, Dysplasia, and Surveillance in Patients with Ulcerative ColitisNew England Journal of Medicine, 1987
- PROSPECTIVE STUDY OF OUTPATIENTS WITH EXTENSIVE COLITISThe Lancet, 1974
- Rectal biopsy as an aid to cancer control in ulcerative colitis.Gut, 1967
- The development of carcinoma of the large intestine in ulcerative colitisBritish Journal of Surgery, 1959